Publications by authors named "Donald Andisik"

Claim this Profile
4
4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
Cathy L Dantzman, Megan M King, Glen E Ernst, Xia Wang, John P McCauley, Donald W Andisik

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications.
John P McCauley, Cathy L Dantzman, Megan M King, Glen E Ernst, Xia Wang, Donald W Andisik

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency.
Philip D Edwards, Jeffrey S Albert, Mark Sylvester, David Aharony, Donald Andisik

J Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
Cyrus J Ohnmacht, Jeffrey S Albert, Peter R Bernstein, William L Rumsey, Brian B Masek, Donald W Andisik

Bioorg Med Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity.
Jeffrey S Albert, David Aharony, Donald Andisik, Herbert Barthlow, Peter R Bernstein

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis